An experimental blood test for prostate cancer may help eliminate tens of thousands of unnecessary biopsies at the same time that it detects many tumors that are now missed by the test commonly used, its developers said yesterday.A friend of mine undergoes a biopsy of his prostate every six to 12 months because his PSA is high. This test conceivably could do away with this painful procedure.PSA, the current test, measures a protein normally produced by the prostate, while the experimental one, called EPCA-2, detects a chemical made principally in cancerous tissue.
Related Posts (on one page):
- Denial of Health Services
- A New Prostate Test
- Prostate Cancer Calls






















